Ontario Pension Board
VC Fund
Toronto, Canada
Ontario Pension Board is a VC fund in Toronto focused on Mobile and Internet. Ontario Pension Board acts as an administrator for the Ontario government's pension plan.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Ontario Pension Board invests in
Stages Ontario Pension Board invests in
Countries Ontario Pension Board invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Mobile 1 (33%)
- Internet 1 (33%)
- Software 1 (33%)
- Recruiting 1 (33%)
- Data Center 1 (33%)
Stage
- Series C 1 (33%)
- Post-IPO Debt 1 (33%)
- Private Equity 1 (33%)
Country
- Canada 1 (33%)
- Sweden 1 (33%)
- United States 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Greg Debicki
Associate Portfolio Manager
|
Associate Portfolio Manager | Total investments: 1 | Find email | |
|
Jeff Stark
Chief Information Security Officer
|
Chief Information Security Officer | Total investments: 0 | Find email | |
|
Vincenza Sera
Chairman
|
Chairman | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Snow Software is changing the way organizations understand and manage their technology consumption. Our technology intelligence platform provides comprehensive visibility and contextual insight across software, SaaS, hardware and cloud. With Snow, IT leaders can effectively optimize resources, enhance performance and enable operational agility in ahybrid world. | $120M / Private Equity / Apr 27, 2017 | ||
| Medicure is a specialty pharmaceutical company focused on the development and commercialization of therapeutics for the U.S. hospital market.Medicure’s vision is to become a leading specialty pharmaceutical company that improves the lives of patients while delivering value for its shareholders. The Company’s current focus is in the area ofacute cardiovascular care, a market served by its commercial product, AGGRASTAT (tirofiban HCl). The Company is also looking to develop and acquire additional hospital products. To accomplish this, the Company is leveraging its historical expertise in clinical development as well as exploring acquisition opportunities with growth potential.Medicure was established in 1997, and spent its first decade focused on research and development. In 2008, the Company began a transition to focus on its commercial, specialty pharmaceutical business. This new direction was solidified in October 2013 with the U.S. FDA approval of the new label for AGGRASTAT. The label change has provided a basis for the Company to grow sales and achieve profitability, and also to pursue development and acquisition opportunities.Medicure’s board and management is committed to building value for its existing shareholder base and is patiently pursuing a long-term view to establishing the Company as a leading, international pharmaceutical company - one that is distinguished by its unique fit within the contemporary market.Medicure Inc. is based in Winnipeg, Canada and publicly traded on the Toronto Stock Exchange Venture under the symbol MPH. Its subsidiaries include Medicure International, Inc. (Barbados), which owns the U.S. rights to AGGRASTAT, as well as two U.S. corporations, Medicure USA, Inc. and Medicure Pharma, Inc., which distributes the Company’s products in the United States. Medicure Inc. and Medicure USA have a minority interest and fixed option to acquire the holding companies of Apicore LLC and Apicore US LLC (collectively, Apicore). Apicore is a developer and manufacturer of specialty Active Pharmaceutical Ingredients (APIs) and generic products (ANDAs). | $60M / Post-IPO Debt / Nov 18, 2016 | ||
| Hired is a career marketplace that matches tech talent with innovative companies. Users on the Hired platform receive objective guidance throughout the interview process from a dedicated Talent Advocate, as well as the ability to compare new opportunities side by side so they can make their next career move with confidence. Employers get access toa hand-picked pool of candidates who are interested in new roles, as well as unmatched transparency into competing offers so they can recruit and hire with insight. The end result is an efficient, effective and enjoyable experience that’s far faster than traditional methods. | $30M / Series C / Nov 09, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ontario Pension Board invest in?
Ontario Pension Board invests primarily in Mobile, Internet and Software startups, most often at Series C and Post-IPO Debt stage. Most of the 3 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ontario Pension Board?
Public channels for Ontario Pension Board include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ontario Pension Board?
The team at Ontario Pension Board includes Greg Debicki (Associate Portfolio Manager), Jeff Stark (Chief Information Security Officer) and Vincenza Sera (Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!